KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Current Leases (2019 - 2023)

Historic Current Leases for Vir Biotechnology (VIR) over the last 4 years, with Q1 2023 value amounting to $7.3 million.

  • Vir Biotechnology's Current Leases changed N/A to $7.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $4.1 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Vir Biotechnology reported Current Leases of $7.3 million as of Q1 2023.
  • In the past 5 years, Vir Biotechnology's Current Leases ranged from a high of $7.3 million in Q1 2023 and a low of $237000.0 during Q4 2019
  • Moreover, its 4-year median value for Current Leases was $300000.0 (2020), whereas its average is $1.8 million.
  • Examining YoY changes over the last 5 years, Vir Biotechnology's Current Leases showed a top increase of 2658.23% in 2020 and a maximum decrease of 2658.23% in 2020.
  • Quarter analysis of 4 years shows Vir Biotechnology's Current Leases stood at $237000.0 in 2019, then increased by 26.58% to $300000.0 in 2020, then surged by 1279.0% to $4.1 million in 2022, then soared by 75.68% to $7.3 million in 2023.
  • Its Current Leases was $7.3 million in Q1 2023, compared to $4.1 million in Q4 2022 and $300000.0 in Q4 2020.